Hypoxic respiratory failure in term newborns: clinical indicators for inhaled nitric oxide and extracorporeal membrane oxygenation therapy

被引:14
|
作者
Fakioglu, H [1 ]
Totapally, BR [1 ]
Torbati, D [1 ]
Raszynski, A [1 ]
Sussmane, JB [1 ]
Wolfsdorf, J [1 ]
机构
[1] Miami Childrens Hosp, Div Crit Care Med, Miami, FL 33155 USA
关键词
extracorporeal membrane oxygenation; hypoxic respiratory failure; inhaled nitric oxide; persistent pulmonary hypertension of newborn; term newborns;
D O I
10.1016/j.jcrc.2005.05.011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: The criteria, for starting extracorporeal membrane oxygenation (ECMO) therapy in term newborn patients with hypoxemic respiratory failure consist of. an oxygenation index (OI) of 25 or higher and alveolar-arterial oxygen (AaO(2)) gradient of more than 600 at sea level. In such. conditions, inhaled. nitric oxide. (iNO) may improve oxygenation and reduce the need for ECMO therapy. We studied early changes in OI and AaO(2) gradients in response to iNO treatment that may indicate a need to continue iNO treatment or the necessity to start an. ECMO therapy. Materials and Methods: In this prospective study, we used 34 outborn neonatal patients that were referred to our pediatric critical care unit in a. children's hospital for ECMO therapy with diagnosis of hypoxemic respiratory failure. In all patients, iNO therapy, starting. at 80 ppm,, was. instituted either during transport or on arrival to hospital. Response, to iNO was assessed after 1 hour, at which time, iNO concentration was reduced to 40 ppm, provided there was more than 20% improvement in either or both oxygenation indices. Patients who,did not respond positively to continuous iNO therapy and met ECMO criteria were given ECMO therapy. Results: Inhaled nitric oxide therapy alone was successful in 10 (29%) of 34 patients. Eighteen patients (53%) required ECMO therapy within the first 10 hours of iNO treatment (early ECMO therapy), whereas. 6 other neonates (18%) became eligible for ECMO therapy after prolonged (2-4 days) iNO treatment (late ECMO therapy). No mortality occurred with. any treatment. Within 4 hours after iNO therapy patients who required early ECMO therapy had significantly higher OI and AaO(2) gradients than patients who were treated with iNO therapy alone. (P <.01, analysis of variance followed by Tukey-Kramer multiple comparison test). Six of 34,patients (18%), categorized as late ECMO therapy, on the average, had initially higher levels of OI and mean airway, pressure than neonates in iNO treatment and early ECMO therapy. Conclusion: Persisting levels of OI of more than 20 or AaO(2) gradients of more than 600 after 4 hours of iNO therapy could be indicative of an immediate need for ECMO therapy. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:288 / 293
页数:6
相关论文
共 50 条
  • [1] Comparison of the oxygenation effect of nebulized nitroprusside to inhaled nitric oxide in term infants with hypoxic respiratory failure
    Gin-Mestan, KK
    Carlson, AD
    White, M
    Powers, JA
    Morgan, S
    Meadow, W
    Schreiber, MD
    PEDIATRIC RESEARCH, 2002, 51 (04) : 50A - 50A
  • [2] Early inhaled nitric oxide therapy in premature newborns with respiratory failure
    Kinsella, John P.
    Cutter, Gary R.
    Walsh, William F.
    Gerstmann, Dale R.
    Bose, Carl L.
    Hart, Claudia
    Sekar, Kris C.
    Auten, Richard L.
    Bhutani, Vinod K.
    Gerdes, Jeffrey S.
    George, Thomas N.
    Southgate, W. Michael
    Carriedo, Heather
    Couser, Robert J.
    Mammel, Mark C.
    Hall, David C.
    Pappagallo, Mariann
    Sardesai, Smeeta
    Strain, John D.
    Baier, Monika
    Abman, Steven H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (04): : 354 - 364
  • [3] Inhaled nitric oxide and treatment of hypoxic respiratory failure
    Ehrenkranz, RA
    ACTA PHARMACOLOGICA SINICA, 1997, 18 (06): : 546 - 547
  • [4] Inhaled nitric oxide and treatment of hypoxic respiratory failure
    Richard A EHRENKRANZ (Department of Pediatrics
    Acta Pharmacologica Sinica, 1997, (06) : 66 - 67
  • [5] Does inhaled nitric oxide (INO) improve oxygenation in respiratory failure in term newborns? - A randomized trial. 1582
    H. Roukema
    K. O'Brien
    A. James
    A. Howlett
    Pediatric Research, 1997, 41 (Suppl 4) : 266 - 266
  • [6] Comparison Of Inhaled Nitric Oxide With Epoprostenol In Hypoxic Respiratory Failure
    Aboeed, A.
    Manickavel, S.
    Mathew, J. J.
    Africano, J.
    Khan, M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [7] Effect of inhaled nitric oxide on oxygen therapy, mechanical ventilation, and hypoxic respiratory failure
    Stewart, Dan L.
    Vogel, Paul A.
    Jarrett, Brant
    Potenziano, Jim
    MINERVA PEDIATRICA, 2018, 70 (01) : 51 - 58
  • [8] Inhaled Nitric Oxide and Hypoxic Respiratory Failure in Term Infants: Neurodevelopmental Follow-Up
    Neil N Finer
    Betty R Vohr
    Charlene M Robertson
    Joel Verter
    Linda L Wright
    Richard A Ehrenkranz
    Pediatric Research, 1999, 45 : 196 - 196
  • [9] Inhaled Nitric Oxide and hypoxic respiratory failure in term infants: Neurodevelopmental follow-up
    Finer, NN
    Vohr, BR
    Robertson, CM
    Verter, J
    Wright, LL
    Ehrenkranz, RA
    PEDIATRIC RESEARCH, 1999, 45 (04) : 196A - 196A
  • [10] Initial dosing of inhaled nitric oxide in infants with hypoxic respiratory failure
    Guthrie, SO
    Walsh, WF
    Auten, KJ
    Clark, RH
    PEDIATRIC RESEARCH, 2003, 53 (04) : 357A - 357A